These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19674986)

  • 1. Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study.
    Venhoff N; Rizzi M; Salzer U; Bossaller L; Thoden J; Eibel H; Walker UA
    Ann Rheum Dis; 2009 Sep; 68(9):1506-8. PubMed ID: 19674986
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab treatment of stiff-person syndrome in a patient with thymoma, diabetes mellitus and autoimmune thyroiditis.
    Dupond JL; Essalmi L; Gil H; Meaux-Ruault N; Hafsaoui C
    J Clin Neurosci; 2010 Mar; 17(3):389-91. PubMed ID: 20071184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment with rituximab in a refractory Stiff-person syndrome].
    Sevy A; Franques J; Chiche L; Pouget J; Attarian S
    Rev Neurol (Paris); 2012 Apr; 168(4):375-8. PubMed ID: 22340864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab.
    Bacorro EA; Tehrani R
    J Clin Rheumatol; 2010 Aug; 16(5):237-9. PubMed ID: 20577094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stiff limb syndrome associated with Hashimoto's encephalopathy: improvement after corticotherapy].
    Calvet D; Touzé E; Delegue P; Bertherat J; Zuber M
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):602-4. PubMed ID: 12072831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy of rituximab in Felty's syndrome.
    Sordet C; Gottenberg JE; Hellmich B; Kieffer P; Mariette X; Sibilia J
    Ann Rheum Dis; 2005 Feb; 64(2):332-3. PubMed ID: 15647445
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment with rituximab of autoimmune haemolytic anaemia causing dialysis-dependent acute renal failure.
    Brown CE; Traynor JP; Sharp RA; Fox JG
    Nephrol Dial Transplant; 2007 Sep; 22(9):2730-1. PubMed ID: 17575312
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of rituximab on immunocompetency in patients with autoimmune disease.
    Looney RJ; Srinivasan R; Calabrese LH
    Arthritis Rheum; 2008 Jan; 58(1):5-14. PubMed ID: 18163518
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.
    Dunkley L; Green M; Gough A
    Rheumatology (Oxford); 2007 Oct; 46(10):1628-9. PubMed ID: 17766999
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical improvement in antiphospholipid syndrome after rituximab therapy.
    Adamson R; Sangle S; Kaul A; Hughes GR; D'Cruz DP
    J Clin Rheumatol; 2008 Dec; 14(6):359-60. PubMed ID: 19033874
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.
    Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY
    Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome.
    Dalakas MC; Rakocevic G; Dambrosia JM; Alexopoulos H; McElroy B
    Ann Neurol; 2017 Aug; 82(2):271-277. PubMed ID: 28749549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of rituximab in rheumatoid arthritis: clinical, biologic, and pharmacogenetic aspects.
    Quartuccio L; Lombardi S; Fabris M; Masolini P; Saracco M; Pellerito R; De Vita S
    Ann N Y Acad Sci; 2009 Sep; 1173():692-700. PubMed ID: 19758217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab treatment in children: comment on the review by Looney et al.
    Bader-Meunier B
    Arthritis Rheum; 2008 Aug; 58(8):2583; author reply 2583-4. PubMed ID: 18668567
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of rituximab in Felty's syndrome.
    Lekharaju V; Chattopadhyay C
    Ann Rheum Dis; 2008 Sep; 67(9):1352. PubMed ID: 18697782
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome.
    Salama A; Schneider U; Dörner T
    Ann Rheum Dis; 2008 Jun; 67(6):894-5. PubMed ID: 18474659
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind crossover study of the L-dopa treatment of torsion dystonia in identical twins.
    Coleman M; Eldridge R; Samler L
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 4935023
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe?
    Zheng WJ; Zhang X; Wang Q; Xu D; Zeng XF; Zhang FC
    Ann Rheum Dis; 2009 Jun; 68(6):1077-8. PubMed ID: 19435726
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy.
    Zeni P; Finger E; Scheinberg MA
    Ann Rheum Dis; 2008 Jul; 67(7):1055-6. PubMed ID: 18556452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.